Bayer AG - Stockholders' Newsletter Second Quarter 2009

News in the second quarter 2009

Active substance florbetaben
Hope in the diagnosis of Alzheimer’s » more

Polycarbonate automotive glazing
Investing in the growing market for automotive glazing » more

Bayer CropScience signs research agreement with charity
Joint malaria research » more

Innovative substance combats fungal diseases in crops
Highly effective at low dosages » more

Silica gel wound dressings
Dressing aims to speed healing of chronic wounds » more

Long-term alliance with the Commonwealth Scientific and Industrial Research Organisation (CSIRO)
Research and development extended to cereal seed » more

News Overview

Key Data
Bayer Group
Net Sales, EBITDA, EBIT, Net income, Cash flow, Non-operating result, Number of Employees » more

Management Report
Overview of Sales, Earnings and Financial Position
The Bayer Group’s businesses turned in a robust performance in the second quarter. » more

Bayer Stock
Investor Information
Including the dividend of €1.40 per share paid on May 13, 2009, the second-quarter performance of Bayer stock came to 10.2%. » more

Focus
Hope in the battle against cancer
Researchers at Bayer HealthCare are working on innovative therapeutic approaches designed to prolong the survival of cancer patients. » more

7:20 min.